Building Better Biologics: Overcoming Hurdles In Protein Therapy Manufacturing

Join industry leaders as they explore the complexities of scaling protein-based therapies from cell line development through commercial drug substance manufacturing. Producing protein therapeutics means navigating real technical hurdles: maintaining batch-to-batch consistency, building scalable processes, and meeting stringent regulatory standards — all simultaneously.

Panelists draw on firsthand manufacturing experience to share what separates successful scale-up initiatives from costly failures. Expect practical strategies around process design, quality systems, and the cross-disciplinary collaboration that makes platform technologies work in practice.

The conversation zeroes in on critical decision points that determine whether a promising protein therapy can become a reliably manufactured commercial product. You'll leave with a clearer picture of the operational realities, compliance considerations, and collaborative frameworks that enable consistent, high-quality production at scale.

Access this webinar to close the gap between development-stage promise and commercial manufacturing success.